Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midostaurin in ASM and MCL
NCT00233454Phase 2Completed
- Start
- Mar 2005
- Primary completion
- Jun 2010
- Countries
- 1
01
Overview
A Phase 2 trial of midostaurin in aggressive systemic mastocytosis (ASM), mast cell leukemia (MCL). Started Mar 2005; status: completed.
02
Drugs
midostaurin
03
Conditions
aggressive systemic mastocytosis (ASM)mast cell leukemia (MCL)
Beyond the preview
Go deeper on NCT00233454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233454.